GSK buys into S Korea's top pharma firm as part of promotional alliance
This article was originally published in Scrip
GlaxoSmithKline has acquired a roughly 10% stake in South Korea's largest pharmaceutical firm, Dong-A Pharmaceuticals, as part of a commercial alliance for selected products in the country.
You may also be interested in...
Join us for a brief audio tour around the past week's major global biopharma industry developments, in this podcast version of Scrip's Five Must-Know Things.
Highlighting progress it has made over the past few years, Japan’s regulatory agency says it wants to raise even further the number of “Japan-first” approvals, as part of its stated mission to get safe and effective new drugs to patients more quickly.
Join us for a brief audio tour around the past week's key developments in the global biopharma industry, in this podcast version of Scrip's Five Must-Know Things.